Small Molecule Inhibitors of Bacterial Efflux Pumps and Methods of Using Same
Summary
EPO granted patent EP3600331A1 to the Regents of the University of Colorado for small molecule inhibitors of bacterial efflux pumps and methods of using same. The invention covers pharmaceutical compositions containing these compounds and methods for treating bacterial infections. The patent is designated for all 31 contracting states including DE, FR, GB, IT, ES, NL, BE, CH, and others.
What changed
EPO published patent EP3600331A1 granting the Regents of the University of Colorado exclusive rights to small molecule inhibitors of bacterial efflux pumps and associated treatment methods. The patent covers compounds classified under A61K 31/65, A61K 31/426, A61K 31/506, and A61K 31/517, along with combination therapies and screening methods under C12Q 1/18.\n\nAffected parties including pharmaceutical manufacturers, biotech companies, and research institutions developing antibiotic therapeutics should conduct freedom-to-operate analyses before commercializing related products in designated EU states. The patent provides market exclusivity through the standard European patent term.
What to do next
- Monitor patent portfolio for freedom-to-operate
- Review designated states for market exclusivity
Archived snapshot
Apr 13, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
SMALL MOLECULE INHIBITORS OF BACTERIAL EFFLUX PUMPS AND METHODS OF USING SAME
Publication EP3600331A1 Kind: A1 Apr 01, 2026
Applicants
The Regents of the University of Colorado,
A Body Corporate
Inventors
REENS, Abigail, L., CROOKS, Amy, L., DETWEILER, Corrella, S.
IPC Classifications
A61K 31/65 20060101AFI20220201BHEP A61K 31/426 20060101ALI20220201BHEP A61K 31/506 20060101ALI20220201BHEP A61K 31/517 20060101ALI20220201BHEP A61P 31/04 20060101ALI20220201BHEP A61K 38/10 20060101ALI20220201BHEP A61K 45/06 20060101ALI20220201BHEP C12Q 1/18 20060101ALI20220201BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.